These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1398513)

  • 1. 'Aggressive' low grade lymphocytic lymphomas can be identified by flow cytometric S-phase determinations.
    Lindh J; Jonsson H; Lenner P; Roos G
    Hematol Oncol; 1992; 10(3-4):171-9. PubMed ID: 1398513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of serum lactic dehydrogenase levels and fraction of S-phase cells in non-Hodgkin lymphomas.
    Lindh J; Lenner P; Osterman B; Roos G
    Eur J Haematol; 1993 May; 50(5):258-63. PubMed ID: 8319787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primarily asymptomatic low-grade non-Hodgkin lymphomas: prediction of symptom-free survival and total survival.
    Martinsson U; Glimelius B; Hagberg H; Sundström C
    Eur J Haematol; 1989 Oct; 43(4):332-8. PubMed ID: 2583259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
    Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
    Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
    Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
    J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomas.
    Mochen C; Giardini R; Costa A; Silvestrini R
    Cell Prolif; 1997 Jan; 30(1):37-47. PubMed ID: 9332493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma.
    Rehn S; Glimelius B; Strang P; Sundström C; Tribukait B
    Hematol Oncol; 1990; 8(1):1-12. PubMed ID: 2298418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.
    Akerman M; Brandt L; Johnson A; Olsson H
    Br J Cancer; 1987 Feb; 55(2):219-23. PubMed ID: 3814492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma.
    Joensuu H; Klemi PJ; Söderström KO; Jalkanen S
    Cancer; 1991 Oct; 68(7):1564-71. PubMed ID: 1893358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma.
    Christensson B; Lindemalm C; Johansson B; Mellstedt H; Tribukait B; Biberfeld P
    Leuk Res; 1989; 13(4):307-14. PubMed ID: 2716347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic parameters in low-grade non-Hodgkin's lymphomas.
    Zemunik T; Vucković J; Forenpoher G; Knezević N; Stula N; Dubravcić M; Ribicić I; Rozga A
    Neoplasma; 1997; 44(1):13-7. PubMed ID: 9201275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas.
    Czader M; Mazur J; Pettersson M; Liliemark J; Strömberg M; Christensson B; Tribukait B; Auer G; Ost A; Porwit A
    Cancer; 1996 Mar; 77(6):1180-8. PubMed ID: 8635141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
    Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
    Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total body irradiation and prednimustine in chronic lymphocytic leukemia and low grade non-Hodgkin's lymphomas. A 9-year experience at a single institution.
    Roncadin M; Arcicasa M; Zagonel V; Bortolus R; Valeri P; Pinto A; De Paoli A; Franchin G; Carbone A; Trovò MG
    Cancer; 1994 Aug; 74(3):978-84. PubMed ID: 8039128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fraction of S-phase cells in blood mononuclear cells in non-Hodgkin's lymphomas--correlation with clinical features and prognosis.
    Lindh J; Jonsson H; Lenner P; Roos G
    Eur J Haematol; 1989 Apr; 42(4):331-8. PubMed ID: 2785930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling.
    Smaaland R; Lote K; Sothern RB; Laerum OD
    Cancer Res; 1993 Jul; 53(13):3129-38. PubMed ID: 8319221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
    Wu HM
    J Tongji Med Univ; 1992; 12(2):65-70. PubMed ID: 1433420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular dendritic cells in extranodal non-Hodgkin lymphomas of MALT and non-MALT type.
    Fellbaum C; Sträter J; Hansmann ML
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):335-41. PubMed ID: 8116224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.